Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guiyang Lidu Drug Technology Development is a pharmaceutical research and development company based in Guiyang, Guizhou Province, China. Founded in 2002, the firm specializes in the synthesis of small molecule chemical drugs and the formulation of traditional Chinese medicines (TCM). The company's primary business model centers on drug discovery, process optimization for generic medications, and the subsequent transfer of these technologies to larger manufacturing partners. Its R&D portfolio includes treatments for cardiovascular diseases, hyperlipidemia, and various inflammatory conditions. Recognized as a National High-tech Enterprise, Guiyang Lidu plays a significant role in the regional pharmaceutical innovation ecosystem of Southwest China by providing technical consulting and R&D services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guiyang Lidu Drug Technology Development.